The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function

Oncogene. 1999 Feb 25;18(8):1589-95. doi: 10.1038/sj.onc.1202479.

Abstract

In order to test if the carboxyl terminal polypeptide of the Retinoblastoma (Rb) tumor suppressor protein, could be used to suppress the growth factor-independent growth phenotype of p210bcr-abl positive myeloid cells, we introduced a truncated form of the 3' end of the Rb cDNA encoding its last 173 amino acid residues (Rb C-box) which localize into the cytoplasm where the p210bcr-abl transforming protein is found, into myeloid cells (32D) which depends on the p210bcr-abl protein for IL3 growth factor-independent growth (32D-p210). The expression of the plasmid vectors carrying the Rb C-box cDNAs was shown to inhibit the abl tyrosine specific protein kinase activity of the p210(bcr-abl) oncoprotein and to suppress the IL3-independent growth phenotype of the 32D-p210 cells. The Rb C-box polypeptides did not suppress the growth of the untransfected 32D parental cell line in methylcellulose in the presence of IL3-conditioned medium. These results suggest that the cytoplasmic localization of the p210(bcr-abl) allows it to escape the effect of intranuclear proteins such as Rb which negatively regulate the p145(c-abl) kinase.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic / genetics*
  • Colony-Forming Units Assay
  • DNA, Complementary / genetics
  • Fusion Proteins, bcr-abl / antagonists & inhibitors*
  • Genes, Retinoblastoma
  • Humans
  • Interleukin-3 / pharmacology
  • Peptide Fragments / physiology*
  • Recombinant Fusion Proteins / physiology
  • Retinoblastoma Protein / physiology*
  • Tetracycline / pharmacology
  • Transcription, Genetic / drug effects
  • Transfection

Substances

  • DNA, Complementary
  • Interleukin-3
  • Peptide Fragments
  • Recombinant Fusion Proteins
  • Retinoblastoma Protein
  • Fusion Proteins, bcr-abl
  • Tetracycline